MaltSci 麦伴科研

Appearance

Popular Reports / cell-biology

This report is written by MaltSci based on the latest literature and research findings

How does cellular senescence contribute to aging? ​

Abstract ​

Aging is a multifaceted biological process characterized by a progressive decline in physiological functions, resulting in increased susceptibility to diseases and mortality. Cellular senescence has emerged as a pivotal factor in this process, defined as an irreversible state of cell cycle arrest triggered by various stressors, including DNA damage and oxidative stress. The accumulation of senescent cells (SnCs) is increasingly recognized as a significant contributor to age-related pathologies, including neurodegenerative diseases, cardiovascular disorders, and cancer. This review elucidates the mechanisms by which cellular senescence influences aging, emphasizing its role in tissue homeostasis and the systemic effects of the senescence-associated secretory phenotype (SASP). The SASP, characterized by the secretion of pro-inflammatory cytokines and other factors, exacerbates tissue degeneration and promotes chronic inflammation, highlighting the detrimental impact of senescent cells on healthspan. Recent advances in understanding the molecular pathways involved in senescence, such as the p53 and p16INK4a signaling pathways, underscore the complexity of this phenomenon and its interplay with inflammation and aging. Moreover, the concept of immunosenescence—declining immune function associated with aging—further illustrates the interconnectedness of senescence and age-related diseases. This review outlines therapeutic approaches targeting senescence, including senolytics and senomorphics, aimed at mitigating the adverse effects of senescence on healthspan and lifespan. By synthesizing current research findings, this review aims to provide a comprehensive overview of the relationship between cellular senescence and aging, emphasizing the potential for innovative interventions to promote healthy aging and enhance quality of life.

Outline ​

This report will discuss the following questions.

  • 1 Introduction
  • 2 Mechanisms of Cellular Senescence
    • 2.1 Triggers of Cellular Senescence
    • 2.2 Molecular Pathways Involved in Senescence
  • 3 Impact of Senescent Cells on Tissue Function
    • 3.1 Senescence-Associated Secretory Phenotype (SASP)
    • 3.2 Role of Senescent Cells in Tissue Repair and Regeneration
  • 4 Senescence and Age-Related Diseases
    • 4.1 Contribution to Inflammatory Diseases
    • 4.2 Role in Cancer Progression
  • 5 Therapeutic Approaches Targeting Senescence
    • 5.1 Senolytics
    • 5.2 Senomorphics and Other Interventions
  • 6 Future Directions in Senescence Research
    • 6.1 Understanding Senescence in Different Cell Types
    • 6.2 Exploring the Link Between Senescence and Systemic Aging
  • 7 Conclusion

1 Introduction ​

Aging is a complex biological process characterized by the progressive decline in physiological functions, leading to increased vulnerability to diseases and ultimately death. Among the myriad of factors contributing to aging, cellular senescence has emerged as a critical phenomenon that significantly impacts healthspan and lifespan. Cellular senescence is defined as a state of irreversible cell cycle arrest that occurs in response to various stressors, including DNA damage, telomere shortening, and oncogenic signals. The accumulation of senescent cells (SnCs) in tissues is increasingly recognized as a major contributor to age-related pathologies, including neurodegenerative diseases, cardiovascular disorders, and cancer[1][2]. This review aims to elucidate the mechanisms by which cellular senescence contributes to the aging process, highlighting its role in tissue homeostasis, its impact on the surrounding microenvironment, and the systemic effects on aging.

The significance of studying cellular senescence in the context of aging cannot be overstated. As the global population ages, understanding the biological underpinnings of aging becomes imperative for developing effective interventions that can mitigate age-related diseases and promote healthy aging. Cellular senescence is not merely a marker of aging; it plays a dual role as both a protective mechanism against tumorigenesis and a contributor to chronic inflammation and tissue dysfunction when senescent cells accumulate[3][4]. The senescence-associated secretory phenotype (SASP), characterized by the secretion of pro-inflammatory cytokines and other factors, has been shown to exacerbate tissue degeneration and promote the progression of age-related diseases[5][6].

Current research has advanced our understanding of the molecular pathways involved in cellular senescence, revealing a complex interplay between senescence, inflammation, and aging. For instance, the activation of key signaling pathways such as p53 and p16INK4a has been implicated in the induction of senescence in response to cellular stress[4][7]. Moreover, the emerging concept of "immunosenescence," which refers to the decline in immune function associated with aging, is closely linked to the accumulation of senescent cells and their pro-inflammatory secretions[8]. This interplay highlights the multifaceted role of cellular senescence in the aging process and underscores the need for targeted therapeutic strategies.

The organization of this review will follow a structured outline. We will begin by exploring the mechanisms of cellular senescence, detailing the triggers and molecular pathways involved in its induction (Section 2). Subsequently, we will examine the impact of senescent cells on tissue function, focusing on the SASP and the role of senescent cells in tissue repair and regeneration (Section 3). We will then discuss the relationship between cellular senescence and age-related diseases, including its contributions to inflammatory diseases and cancer progression (Section 4). In light of the detrimental effects of senescence, we will explore therapeutic approaches targeting senescence, such as senolytics and senomorphics, aimed at mitigating its adverse effects on healthspan and lifespan (Section 5). Lastly, we will outline future directions in senescence research, emphasizing the need to understand senescence in different cell types and its systemic implications for aging (Section 6).

By synthesizing current research findings, this review seeks to provide a comprehensive overview of the interplay between cellular senescence and aging. Understanding this relationship is crucial for developing innovative interventions that can promote healthy aging and enhance the quality of life in an increasingly aging population. As we delve into the complexities of cellular senescence, we aim to shed light on the potential for therapeutic strategies that target this process, paving the way for future advancements in gerontology and regenerative medicine.

2 Mechanisms of Cellular Senescence ​

2.1 Triggers of Cellular Senescence ​

Cellular senescence is a crucial biological process that significantly contributes to aging and age-related diseases. It is characterized by an irreversible state of cell cycle arrest, which occurs in response to various stressors, including oxidative stress, DNA damage, and other cellular insults. The accumulation of senescent cells (SnCs) is observed with advancing age and is linked to the progression of numerous chronic degenerative disorders.

One of the primary mechanisms by which cellular senescence contributes to aging is through the senescence-associated secretory phenotype (SASP). Senescent cells secrete a variety of pro-inflammatory cytokines, chemokines, and extracellular matrix components that can lead to chronic inflammation and tissue dysfunction. This inflammatory milieu exacerbates age-related pathologies such as cardiovascular diseases, neurodegenerative disorders, and metabolic syndromes [5].

The triggers of cellular senescence are diverse. They include intrinsic factors like telomere shortening and genomic instability, as well as extrinsic factors such as oxidative stress and inflammatory cytokines. For instance, the activation of the p53 and p16INK4a pathways in response to DNA damage is a well-established mechanism that induces senescence. These pathways halt the cell cycle, preventing the proliferation of damaged cells, which is a critical tumor-suppressive function. However, the persistent presence of senescent cells can lead to a decline in tissue homeostasis and regenerative capacity, contributing to the aging process [1].

Moreover, recent studies have highlighted the role of cellular senescence in various physiological contexts, including embryogenesis and tissue repair. In these scenarios, senescent cells can facilitate tissue remodeling and regeneration. However, when senescence becomes chronic, as seen in aging, it can lead to detrimental effects on tissue function [9]. The dual role of senescence—as both a protective mechanism against tumorigenesis and a contributor to aging—illustrates its complexity and the need for targeted therapeutic strategies to modulate its effects [3].

Furthermore, the relationship between cellular senescence and aging is underscored by the accumulation of senescent cells in various tissues over time. This accumulation is linked to a decline in the regenerative capacity of tissues, leading to a decreased ability to repair damage and maintain homeostasis, which are hallmark features of aging [10].

In summary, cellular senescence is a multifaceted process that plays a significant role in the aging process through mechanisms involving the accumulation of senescent cells, the secretion of inflammatory factors via the SASP, and the triggers that induce senescence. Understanding these mechanisms provides insight into potential therapeutic interventions aimed at mitigating the effects of aging and enhancing healthspan.

2.2 Molecular Pathways Involved in Senescence ​

Cellular senescence is a critical biological process that significantly contributes to aging through a variety of mechanisms and molecular pathways. It is characterized by an irreversible growth arrest of somatic cells, which can be triggered by various stressors such as DNA damage, telomere shortening, and oxidative stress. While senescence serves protective roles against tumorigenesis and facilitates tissue repair, the accumulation of senescent cells over time is closely associated with aging and age-related diseases.

One of the key features of cellular senescence is the senescence-associated secretory phenotype (SASP), which refers to the secretion of pro-inflammatory cytokines, chemokines, and growth factors by senescent cells. The SASP can induce chronic inflammation and tissue dysfunction, linking cellular senescence to various age-related conditions, including cardiovascular diseases, neurodegenerative disorders, and metabolic syndromes (Alum et al. 2025; Wu et al. 2025). The persistent inflammatory environment created by the SASP can exacerbate the aging process and lead to further cellular damage, thereby perpetuating a cycle of aging and disease progression.

Molecularly, several pathways are implicated in the induction and maintenance of cellular senescence. The p53/p21 and p16INK4a/pRb pathways are critical regulators of the cell cycle and are often activated in response to cellular stressors. Activation of these pathways leads to cell cycle arrest, preventing the proliferation of damaged cells (Klepacki et al. 2025). The accumulation of senescent cells, particularly in tissues, is associated with a decline in regenerative capacity and an increase in tissue dysfunction, contributing to the aging phenotype (Ogrodnik et al. 2019).

Moreover, the interplay between cellular senescence and metabolic processes is noteworthy. Metabolic dysregulation in senescent cells can influence the SASP and the overall cellular environment, further linking metabolism to aging (Shmulevich & Krizhanovsky 2021). Mitochondrial dysfunction has also been identified as a significant factor in cellular senescence, with alterations in mitochondrial function contributing to the senescence phenotype and the induction of the SASP (Chapman et al. 2019).

In summary, cellular senescence contributes to aging through a complex interplay of molecular pathways that promote cell cycle arrest, inflammation, and metabolic changes. The accumulation of senescent cells, coupled with their secretory profiles, drives the progression of age-related diseases and diminishes tissue function, ultimately impacting the healthspan and lifespan of organisms. Continued research into these mechanisms may reveal novel therapeutic strategies aimed at mitigating the effects of senescence on aging and enhancing health in the elderly population (Kang 2019; Ajoolabady et al. 2025).

3 Impact of Senescent Cells on Tissue Function ​

3.1 Senescence-Associated Secretory Phenotype (SASP) ​

Cellular senescence is characterized by an irreversible cell cycle arrest that occurs in response to various stressors, including DNA damage and oxidative stress. This phenomenon plays a significant role in the aging process and is intricately linked to the development of age-related diseases. One of the critical aspects of cellular senescence is the senescence-associated secretory phenotype (SASP), which encompasses a range of bioactive factors secreted by senescent cells, including pro-inflammatory cytokines, chemokines, growth factors, and proteases. The SASP can have both beneficial and detrimental effects on tissue function and overall health, depending on the context in which senescence occurs.

Senescent cells accumulate in various tissues as organisms age, contributing to a state of chronic, low-grade inflammation that is a hallmark of aging. This inflammatory environment can exacerbate the progression of age-related diseases such as atherosclerosis, osteoarthritis, and neurodegenerative disorders. The SASP factors released by senescent cells can disrupt the local tissue microenvironment, promoting pathological changes and influencing the behavior of neighboring cells. For instance, the SASP has been shown to stimulate tumor progression by creating a pro-inflammatory niche that supports cancer cell survival and proliferation[11].

In the context of tissue regeneration, the role of senescent cells and their SASP is complex. While transient senescence can facilitate tissue repair following injury, persistent senescence is often detrimental to tissue regeneration. Studies indicate that the accumulation of senescent cells can impair the regenerative capacity of tissues, particularly in aged organisms[12]. This duality highlights the context-dependent nature of senescent cells; their presence may be beneficial in early stages of injury repair but can become harmful if they persist and continue to secrete SASP factors that induce chronic inflammation and tissue dysfunction[13].

Furthermore, specific tissues exhibit unique responses to senescence and SASP. For example, in skeletal tissues, senescent cells contribute to conditions like osteoporosis by promoting bone resorption and impairing bone formation through the action of SASP factors[14]. Similarly, in cardiac tissues, senescence has been linked to heart failure and myocardial ischemia, where the SASP influences cardiac remodeling and function[15].

Overall, the interplay between cellular senescence, the SASP, and tissue function underscores the complexity of aging and age-related diseases. As research progresses, targeting senescent cells and modulating the SASP emerges as a promising therapeutic strategy to mitigate the adverse effects of aging and improve healthspan[16].

In conclusion, cellular senescence contributes to aging through the accumulation of senescent cells that secrete the SASP, leading to chronic inflammation and tissue dysfunction. The context-dependent effects of senescent cells highlight their potential dual roles in both promoting and impairing tissue health, necessitating further investigation into therapeutic interventions aimed at managing senescence and its associated secretory phenotype.

3.2 Role of Senescent Cells in Tissue Repair and Regeneration ​

Cellular senescence is a crucial biological process characterized by a permanent state of cell cycle arrest, which can significantly influence aging and age-related diseases. The accumulation of senescent cells (SnCs) within tissues contributes to various pathologies associated with aging, including degenerative diseases, chronic inflammation, and impaired tissue function.

Senescent cells are metabolically active but fail to proliferate, leading to a range of phenotypic changes that include the secretion of pro-inflammatory cytokines, growth factors, and proteases, collectively termed the senescence-associated secretory phenotype (SASP). This secretory profile can have detrimental effects on neighboring cells and tissues, promoting chronic inflammation and tissue dysfunction, which are hallmarks of aging (Wu et al., 2025; Ajoolabady et al., 2025).

The role of senescent cells in tissue repair and regeneration is complex. While senescence has traditionally been viewed as a detrimental process contributing to aging, emerging evidence suggests that senescent cells also play essential roles in normal physiological processes such as wound healing and tissue remodeling. For instance, during tissue repair, senescent cells can secrete factors that promote inflammation and tissue regeneration, thereby facilitating the repair process (Walters & Yun, 2020; McHugh & Gil, 2018). However, if senescent cells accumulate excessively or fail to be cleared, their pro-inflammatory effects can lead to tissue degeneration and contribute to age-related diseases.

In the context of tissue function, the accumulation of senescent cells can impair the regenerative capacity of tissues. For example, in the skin, senescent fibroblasts contribute to the decline in tissue elasticity and the appearance of wrinkles by altering the extracellular matrix and promoting inflammation (Smith & Carroll, 2025). Similarly, in the lungs, senescent epithelial cells have been implicated in the pathogenesis of chronic obstructive pulmonary disease (COPD) and pulmonary fibrosis, where their persistent presence disrupts normal lung function and repair mechanisms (Hansel et al., 2020).

Moreover, senescence has been linked to the development of neurodegenerative diseases, where the accumulation of senescent cells in the nervous system may predispose individuals to conditions such as Alzheimer's disease and Parkinson's disease. The inflammatory milieu generated by senescent cells can exacerbate neuroinflammation and neuronal damage, further complicating the pathology of these diseases (Kritsilis et al., 2018; Jaganathan et al., 2025).

In summary, cellular senescence plays a dual role in aging: it acts as a barrier to tumorigenesis and contributes to tissue repair, yet its accumulation can lead to detrimental effects on tissue function and promote age-related diseases. Understanding the mechanisms of senescence and developing strategies to modulate its effects could offer therapeutic avenues to enhance tissue regeneration and mitigate the impacts of aging. Targeting senescent cells through senolytic therapies, which selectively eliminate senescent cells, has shown promise in preclinical models and may represent a viable strategy for improving healthspan and treating age-related conditions (Wang et al., 2025; Amaya-Montoya et al., 2020).

4 Senescence and Age-Related Diseases ​

4.1 Contribution to Inflammatory Diseases ​

Cellular senescence is a crucial biological process that significantly contributes to aging and the development of age-related diseases, particularly through its role in chronic inflammation. As organisms age, an accumulation of senescent cells occurs, which are characterized by a permanent cessation of cell proliferation and a distinct secretory phenotype known as the senescence-associated secretory phenotype (SASP). This phenotype is marked by the secretion of pro-inflammatory cytokines, chemokines, and other factors that can lead to chronic low-grade inflammation, a phenomenon often referred to as "inflammaging"[6][17].

The SASP plays a pivotal role in the pathogenesis of various chronic inflammatory diseases associated with aging, including cardiovascular diseases, diabetes, neurodegenerative disorders, and certain cancers[18][19]. The inflammatory environment created by senescent cells can promote tissue dysfunction and exacerbate the progression of age-related diseases. For instance, the presence of senescent cells in tissues can lead to an increase in local inflammation, which is a key contributor to conditions such as atherosclerosis and osteoarthritis[20][21].

In the context of inflammatory lung diseases, recent studies have highlighted how the accumulation of senescent cells and their SASP components can exacerbate conditions like chronic obstructive pulmonary disease (COPD) and idiopathic pulmonary fibrosis (IPF). These diseases are characterized by chronic inflammation and progressive tissue damage, where senescent cells contribute to the inflammatory milieu, thus perpetuating the cycle of damage and senescence[21][22].

Furthermore, cellular senescence is not merely a consequence of aging but is also implicated in the mechanisms that drive age-related pathologies. The accumulation of senescent cells can lead to a decline in tissue regeneration and function, further exacerbating age-related health issues. For example, senescent cells have been shown to negatively influence the regenerative capacity of stem cells, leading to a decrease in tissue homeostasis and an increased risk of chronic diseases[23][24].

Research has also indicated that the interplay between cellular senescence and the immune system, particularly immunosenescence, contributes to the overall aging process. Immunosenescence refers to the decline in immune function with age, which can be further aggravated by the chronic inflammation driven by senescent cells. This relationship highlights a vicious cycle where senescence promotes inflammation, and inflammation, in turn, accelerates the accumulation of senescent cells[8][25].

In summary, cellular senescence contributes to aging and age-related diseases through its role in driving chronic inflammation. The accumulation of senescent cells and their SASP components creates a pro-inflammatory environment that leads to tissue dysfunction and exacerbates various chronic conditions. Understanding these mechanisms opens avenues for therapeutic interventions aimed at targeting senescent cells, potentially mitigating their detrimental effects on health during aging[6][18].

4.2 Role in Cancer Progression ​

Cellular senescence is a critical biological process that plays a significant role in aging and the development of age-related diseases, including cancer. It is characterized by a stable and irreversible cell cycle arrest in response to various stressors, including DNA damage, oxidative stress, and other forms of cellular stress. This state of senescence is associated with a distinct phenotype known as the senescence-associated secretory phenotype (SASP), which involves the secretion of pro-inflammatory cytokines, chemokines, and other factors that can influence the surrounding tissue microenvironment.

The accumulation of senescent cells in tissues is a hallmark of aging and is linked to the deterioration of tissue function and the onset of age-related diseases. Specifically, senescent cells can contribute to the aging process through several mechanisms:

  1. Inflammation and Tissue Dysfunction: Senescent cells secrete a variety of inflammatory factors that can lead to chronic inflammation, a condition often referred to as "inflammaging." This chronic inflammation can promote tissue degeneration and dysfunction, contributing to the development of various age-related conditions, including cardiovascular diseases and neurodegenerative disorders [6][26].

  2. Tumorigenesis: While cellular senescence acts as a protective mechanism to prevent the proliferation of damaged cells, the persistent presence of senescent cells can paradoxically promote tumorigenesis. The SASP factors released by senescent cells can create a pro-tumorigenic microenvironment, facilitating the growth and spread of nearby cancer cells [6][27]. This dual role of senescence is critical in understanding its implications for cancer progression.

  3. Impact on Stem Cell Function: Cellular senescence can impair the regenerative capacity of stem cells. The accumulation of senescent cells in stem cell niches can disrupt the balance between stem cell renewal and differentiation, ultimately leading to a decline in tissue regeneration and repair mechanisms [28].

  4. Crosstalk with Other Cellular Processes: Cellular senescence interacts with various cellular processes, including autophagy and apoptosis, which are crucial for maintaining cellular homeostasis. Dysregulation of these processes in senescent cells can exacerbate aging-related tissue dysfunction [4].

  5. Role in Age-Related Diseases: The presence of senescent cells has been linked to a range of age-related diseases, including neurodegenerative diseases, diabetes, and cardiovascular diseases. For instance, senescent cells in the brain can contribute to cognitive decline and neuroinflammation, exacerbating conditions like Alzheimer's disease [10][29].

In conclusion, cellular senescence significantly contributes to the aging process and the pathogenesis of age-related diseases through mechanisms involving chronic inflammation, impaired tissue regeneration, and potential promotion of cancer progression. The intricate interplay between senescence and various cellular processes underscores the importance of targeting senescent cells in therapeutic strategies aimed at mitigating the effects of aging and improving healthspan [5][30].

5 Therapeutic Approaches Targeting Senescence ​

5.1 Senolytics ​

Cellular senescence is a crucial biological process characterized by irreversible cell cycle arrest in response to various stressors, including oxidative stress, DNA damage, and telomere shortening. This phenomenon plays a significant role in aging, as the accumulation of senescent cells (SnCs) contributes to the deterioration of tissue function and the development of age-related diseases. The senescence-associated secretory phenotype (SASP) is a hallmark of senescent cells, which involves the secretion of pro-inflammatory cytokines, chemokines, and matrix-degrading enzymes. The SASP can lead to chronic inflammation and disrupt tissue homeostasis, exacerbating age-related pathologies such as neurodegenerative diseases, cardiovascular conditions, and metabolic disorders [10][31][32].

As individuals age, the ability to maintain homeostasis declines, and the accumulation of senescent cells in various tissues becomes evident. These cells can promote local inflammation and tissue dysfunction, contributing to the onset and progression of age-related diseases. In the brain, for instance, cellular senescence has been linked to neurodegenerative disorders such as Alzheimer's disease and Parkinson's disease, where senescent cells contribute to neuroinflammation and cognitive decline [10][29]. Similarly, in the context of the skeletal system, senescent cells have been shown to play a role in age-related bone loss and osteoporosis [33].

Given the detrimental effects of senescent cells on health and longevity, therapeutic strategies targeting cellular senescence have garnered significant interest. Senolytics are a class of drugs designed to selectively eliminate senescent cells, thereby alleviating the negative impact of their accumulation. These compounds have shown promise in preclinical studies, demonstrating their potential to improve healthspan and mitigate age-related diseases [34][35].

Emerging evidence suggests that various senolytic agents, including natural compounds such as quercetin, fisetin, and dasatinib, can effectively reduce the burden of senescent cells in animal models [36][37]. These agents not only target senescent cells but also modulate the SASP, thereby reducing chronic inflammation and restoring tissue function. Clinical trials are currently underway to evaluate the efficacy of these senolytic therapies in humans, with the aim of translating preclinical findings into effective treatments for age-related conditions [35][38].

In summary, cellular senescence significantly contributes to the aging process through mechanisms involving chronic inflammation and tissue dysfunction. Targeting senescence with senolytic therapies presents a promising approach to promote healthy aging and address age-related diseases, highlighting the need for continued research and clinical validation in this rapidly evolving field.

5.2 Senomorphics and Other Interventions ​

Cellular senescence is a critical biological process that significantly contributes to aging and age-related diseases. It is characterized by a permanent state of cell cycle arrest in response to various stressors, such as DNA damage, oxidative stress, and telomere shortening. While senescence plays a protective role in tumor suppression and tissue repair, the accumulation of senescent cells over time can lead to detrimental effects, including chronic inflammation and tissue dysfunction, primarily through the secretion of pro-inflammatory factors known as the senescence-associated secretory phenotype (SASP) [32].

The SASP comprises a range of cytokines, chemokines, and growth factors that can promote local inflammation and alter the tissue microenvironment, ultimately contributing to the progression of age-related diseases such as cardiovascular conditions, neurodegenerative disorders, and metabolic syndromes [39]. As senescent cells accumulate, they can exacerbate chronic inflammation and tissue degeneration, thus accelerating the aging process and the onset of age-related pathologies [5].

In terms of therapeutic approaches targeting cellular senescence, two primary strategies have emerged: senolytics and senomorphics. Senolytics are compounds designed to selectively eliminate senescent cells, thereby reducing the overall burden of these cells and their associated inflammatory effects. Examples of senolytic agents include dasatinib and quercetin, which have shown promise in preclinical and clinical studies for their ability to improve healthspan and mitigate age-related diseases [10].

On the other hand, senomorphics are designed to modulate the SASP without necessarily killing senescent cells. These compounds aim to inhibit the detrimental effects of the SASP while preserving the beneficial aspects of senescence, such as tissue repair and regeneration [29]. This dual approach allows for a more nuanced strategy in addressing the negative consequences of cellular senescence, potentially leading to better therapeutic outcomes.

Lifestyle interventions, such as calorie restriction and regular physical exercise, have also been identified as natural modulators of senescence pathways. These interventions can enhance the body’s ability to manage cellular senescence and its associated effects, thus contributing to healthier aging [32].

In summary, cellular senescence plays a pivotal role in the aging process by promoting chronic inflammation and tissue dysfunction through the accumulation of senescent cells and the SASP. Therapeutic strategies targeting this process, including senolytics and senomorphics, hold promise for mitigating age-related diseases and improving healthspan. Continued research into these interventions, alongside lifestyle modifications, may pave the way for effective strategies to promote healthy aging and combat the effects of cellular senescence.

6 Future Directions in Senescence Research ​

6.1 Understanding Senescence in Different Cell Types ​

Cellular senescence is a critical biological process characterized by a permanent state of cell cycle arrest that occurs in response to various stressors, including DNA damage, oxidative stress, and other forms of cellular insult. This phenomenon plays a significant role in aging and the development of age-related diseases. The accumulation of senescent cells (SnCs) in tissues contributes to the aging process by promoting chronic inflammation, oxidative stress, and tissue dysfunction, which are hallmarks of aging and degenerative diseases.

The relationship between cellular senescence and aging is multifaceted. Senescent cells are metabolically active and secrete a variety of pro-inflammatory factors known as the senescence-associated secretory phenotype (SASP). These factors can have detrimental effects on neighboring cells and tissues, exacerbating inflammation and leading to further tissue damage. For instance, the SASP has been implicated in the progression of several age-related conditions, including cardiovascular diseases, neurodegenerative disorders, and various forms of cancer [2][3][5].

Understanding the mechanisms of cellular senescence is crucial for elucidating its role in aging. Recent studies have highlighted the differential regulatory mechanisms of specific signaling pathways involved in senescence across various cell types. This indicates that the effects of senescence may vary depending on the cellular context, suggesting that targeted interventions could be tailored to specific tissues or conditions [5].

Future directions in senescence research involve a deeper exploration of the specific roles of senescent cells in different tissues and under various pathological conditions. For example, while senescence can act as a protective mechanism against tumorigenesis, its persistent activation in tissues can lead to detrimental outcomes, including fibrosis and degeneration [9]. Investigating the context-dependent effects of senescence may lead to novel therapeutic strategies aimed at selectively targeting senescent cells or modulating their secretory profiles.

Moreover, there is a growing interest in developing senolytic agents—drugs that selectively induce death in senescent cells. These agents have shown promise in preclinical models by improving health span and potentially extending lifespan by clearing senescent cells from tissues [16][40].

In conclusion, cellular senescence significantly contributes to the aging process through its role in promoting inflammation and tissue dysfunction. The understanding of senescence is evolving, with ongoing research aimed at unraveling its complex biology in different cell types and developing targeted therapies to mitigate its adverse effects in age-related diseases. This line of inquiry not only holds potential for improving health outcomes in aging populations but also offers insights into the fundamental biology of aging itself.

6.2 Exploring the Link Between Senescence and Systemic Aging ​

Cellular senescence is increasingly recognized as a significant contributor to the aging process, playing a central role in the development of various age-related diseases. This phenomenon involves a stable cell cycle arrest that occurs in response to stressors such as DNA damage, oxidative stress, and other forms of cellular injury. As organisms age, the accumulation of senescent cells can lead to a decline in tissue function and regenerative capacity, thereby exacerbating the aging process and contributing to the onset of chronic diseases.

The accumulation of senescent cells is particularly problematic due to their secretion of pro-inflammatory factors, collectively known as the senescence-associated secretory phenotype (SASP). This secretome not only promotes chronic inflammation but also disrupts normal tissue homeostasis, leading to further cellular damage and dysfunction. In the context of aging, the SASP can have systemic effects, contributing to the development of conditions such as cardiovascular diseases, neurodegenerative disorders, and metabolic syndromes [5][9][10].

Recent studies have begun to elucidate the mechanisms by which cellular senescence influences systemic aging. For instance, senescent cells can induce local and systemic inflammation, which has been linked to a decline in immune function, known as immunosenescence. This decline further accelerates aging by impairing the body's ability to respond to infections and repair damaged tissues [8][10]. Additionally, the presence of senescent cells in tissues can alter the local microenvironment, leading to impaired regeneration and increased susceptibility to age-related diseases [3][16].

Future research directions in the field of cellular senescence and aging are focused on several key areas. First, there is a need for a deeper understanding of the signaling pathways that regulate cellular senescence and the SASP. Identifying these pathways could reveal novel therapeutic targets for interventions aimed at mitigating the effects of senescence on aging [5][9].

Moreover, the development of senolytic therapies—agents that selectively eliminate senescent cells—has shown promise in preclinical models. These therapies aim to reduce the burden of senescent cells and their deleterious effects on tissue function and systemic health. Preliminary evidence suggests that such interventions may improve health span and potentially extend lifespan by alleviating the inflammatory burden associated with senescence [10][16].

Another important avenue of research involves exploring the relationship between cellular senescence and various age-related diseases, particularly neurodegenerative conditions. Understanding how senescent cells contribute to the pathophysiology of diseases like Alzheimer's and Parkinson's may provide insights into targeted therapeutic strategies [2][10].

In conclusion, cellular senescence plays a pivotal role in aging by promoting inflammation, impairing tissue function, and contributing to the onset of chronic diseases. Continued research into the mechanisms of senescence and its systemic effects will be crucial for developing effective interventions to combat the negative impacts of aging and improve overall health in older adults.

7 Conclusion ​

Cellular senescence is a critical biological process that significantly influences aging and age-related diseases through various mechanisms. The accumulation of senescent cells leads to chronic inflammation, tissue dysfunction, and a decline in regenerative capacity, which are hallmark features of aging. The dual role of senescence, acting as both a protective mechanism against tumorigenesis and a contributor to age-related pathologies, highlights the complexity of this phenomenon. Current research emphasizes the need for targeted therapeutic strategies, such as senolytics and senomorphics, to mitigate the adverse effects of senescence on healthspan and lifespan. Furthermore, future research directions should focus on understanding the role of senescence in different cell types and its systemic implications for aging, paving the way for innovative interventions that promote healthy aging and improve quality of life in an increasingly aging population.

References ​

  • [1] Angela Grimes;Sathees B C Chandra. Significance of cellular senescence in aging and cancer.. Cancer research and treatment(IF=3.8). 2009. PMID:20057963. DOI: 10.4143/crt.2009.41.4.187.
  • [2] Mikolaj Ogrodnik;Hanna Salmonowicz;Vadim N Gladyshev. Integrating cellular senescence with the concept of damage accumulation in aging: Relevance for clearance of senescent cells.. Aging cell(IF=7.1). 2019. PMID:30346102. DOI: 10.1111/acel.12841.
  • [3] Arianna Calcinotto;Jaskaren Kohli;Elena Zagato;Laura Pellegrini;Marco Demaria;Andrea Alimonti. Cellular Senescence: Aging, Cancer, and Injury.. Physiological reviews(IF=28.7). 2019. PMID:30648461. DOI: 10.1152/physrev.00020.2018.
  • [4] Amir Ajoolabady;Domenico Pratico;Suhad Bahijri;Basmah Eldakhakhny;Jaakko Tuomilehto;Feng Wu;Jun Ren. Hallmarks and mechanisms of cellular senescence in aging and disease.. Cell death discovery(IF=7.0). 2025. PMID:40759632. DOI: 10.1038/s41420-025-02655-x.
  • [5] Junying Wu;Xiuxing Liu;Yidan Liu;Wenru Su;Yehong Zhuo. New Insights into the Role of Cellular Senescence and Its Therapeutic Implications in Ocular Diseases.. Bioengineering (Basel, Switzerland)(IF=3.7). 2025. PMID:40564380. DOI: 10.3390/bioengineering12060563.
  • [6] Domhnall McHugh;Jesús Gil. Senescence and aging: Causes, consequences, and therapeutic avenues.. The Journal of cell biology(IF=6.4). 2018. PMID:29114066. DOI: 10.1083/jcb.201708092.
  • [7] Darya Bulbiankova;Rocío Díaz-Puertas;Francisco Javier Álvarez-Martínez;María Herranz-López;Enrique Barrajón-Catalán;Vicente Micol. Hallmarks and Biomarkers of Skin Senescence: An Updated Review of Skin Senotherapeutics.. Antioxidants (Basel, Switzerland)(IF=6.6). 2023. PMID:36830002. DOI: 10.3390/antiox12020444.
  • [8] Shuaiqi Wang;Tong Huo;Mingyang Lu;Yueqi Zhao;Jianmin Zhang;Wei He;Hui Chen. Recent Advances in Aging and Immunosenescence: Mechanisms and Therapeutic Strategies.. Cells(IF=5.2). 2025. PMID:40214453. DOI: 10.3390/cells14070499.
  • [9] Vasco Lucas;Cláudia Cavadas;Célia Alexandra Aveleira. Cellular Senescence: From Mechanisms to Current Biomarkers and Senotherapies.. Pharmacological reviews(IF=17.3). 2023. PMID:36732079. DOI: 10.1124/pharmrev.122.000622.
  • [10] Ravindran Jaganathan;Ashok Iyaswamy;Senthilkumar Krishnamoorthi;Abhimanyu Thakur;Siva Sundara Kumar Durairajan;Chuanbin Yang;Dapkupar Wankhar. Current aspects of targeting cellular senescence for the therapy of neurodegenerative diseases.. Frontiers in aging neuroscience(IF=4.5). 2025. PMID:41079999. DOI: 10.3389/fnagi.2025.1627921.
  • [11] Albert R Davalos;Jean-Philippe Coppe;Judith Campisi;Pierre-Yves Desprez. Senescent cells as a source of inflammatory factors for tumor progression.. Cancer metastasis reviews(IF=8.7). 2010. PMID:20390322. DOI: 10.1007/s10555-010-9220-9.
  • [12] Victoria Moiseeva;Andrés Cisneros;Aina Calls Cobos;Aida Beà Tarrega;Claudia Santos Oñate;Eusebio Perdiguero;Antonio L Serrano;Pura Muñoz-Cánoves. Context-dependent roles of cellular senescence in normal, aged, and disease states.. The FEBS journal(IF=4.2). 2023. PMID:35811491. DOI: 10.1111/febs.16573.
  • [13] Priyanka Banerjee;Niyanshi Gaddam;Tej K Pandita;Sanjukta Chakraborty. Cellular Senescence as a Brake or Accelerator for Oncogenic Transformation and Role in Lymphatic Metastasis.. International journal of molecular sciences(IF=4.9). 2023. PMID:36769195. DOI: 10.3390/ijms24032877.
  • [14] Ke Li;Sihan Hu;Hao Chen. Cellular senescence and other age-related mechanisms in skeletal diseases.. Bone research(IF=15.0). 2025. PMID:40623977. DOI: 10.1038/s41413-025-00448-7.
  • [15] Mozhdeh Mehdizadeh;Martin Aguilar;Eric Thorin;Gerardo Ferbeyre;Stanley Nattel. The role of cellular senescence in cardiac disease: basic biology and clinical relevance.. Nature reviews. Cardiology(IF=44.2). 2022. PMID:34667279. DOI: 10.1038/s41569-021-00624-2.
  • [16] Mateo Amaya-Montoya;Agustín Pérez-Londoño;Valentina Guatibonza-García;Andrea Vargas-Villanueva;Carlos O Mendivil. Cellular Senescence as a Therapeutic Target for Age-Related Diseases: A Review.. Advances in therapy(IF=4.0). 2020. PMID:32185730. DOI: 10.1007/s12325-020-01287-0.
  • [17] Yi Zhu;Jacqueline L Armstrong;Tamara Tchkonia;James L Kirkland. Cellular senescence and the senescent secretory phenotype in age-related chronic diseases.. Current opinion in clinical nutrition and metabolic care(IF=3.5). 2014. PMID:24848532. DOI: 10.1097/MCO.0000000000000065.
  • [18] Hadis Shakeri;Katrien Lemmens;Andreas B Gevaert;Guido R Y De Meyer;Vincent F M Segers. Cellular senescence links aging and diabetes in cardiovascular disease.. American journal of physiology. Heart and circulatory physiology(IF=4.1). 2018. PMID:29750567. DOI: 10.1152/ajpheart.00287.2018.
  • [19] Makoto Nakanishi. Cellular senescence as a source of chronic microinflammation that promotes the aging process.. Proceedings of the Japan Academy. Series B, Physical and biological sciences(IF=4.6). 2025. PMID:40222899. DOI: 10.2183/pjab.101.014.
  • [20] Gang Li;Dengqin He;Xiaojia Cai;Wen Guan;Yali Zhang;Jia-Qiang Wu;Hongliang Yao. Advances in the development of phosphodiesterase-4 inhibitors.. European journal of medicinal chemistry(IF=5.9). 2023. PMID:36809706. DOI: 10.1016/j.ejmech.2023.115195.
  • [21] Cong Xie;Mai Maititusun Ya Likun;Qing-Li Luo;Jing-Cheng Dong. Role of cellular senescence in inflammatory lung diseases.. Cytokine & growth factor reviews(IF=11.8). 2023. PMID:36797117. DOI: 10.1016/j.cytogfr.2023.02.001.
  • [22] Jodie Birch;Peter J Barnes;Joao F Passos. Mitochondria, telomeres and cell senescence: Implications for lung ageing and disease.. Pharmacology & therapeutics(IF=12.5). 2018. PMID:28987319. DOI: 10.1016/j.pharmthera.2017.10.005.
  • [23] Chanhee Kang. Senolytics and Senostatics: A Two-Pronged Approach to Target Cellular Senescence for Delaying Aging and Age-Related Diseases.. Molecules and cells(IF=6.5). 2019. PMID:31838837. DOI: 10.14348/molcells.2019.0298.
  • [24] Anna Calabrò;Giulia Accardi;Anna Aiello;Calogero Caruso;Damiano Galimberti;Giuseppina Candore. Senotherapeutics to Counteract Senescent Cells Are Prominent Topics in the Context of Anti-Ageing Strategies.. International journal of molecular sciences(IF=4.9). 2024. PMID:38339070. DOI: 10.3390/ijms25031792.
  • [25] Leane Perim Rodrigues;Vitória Rodrigues Teixeira;Thuany Alencar-Silva;Bianca Simonassi-Paiva;Rinaldo Wellerson Pereira;Robert Pogue;Juliana Lott Carvalho. Hallmarks of aging and immunosenescence: Connecting the dots.. Cytokine & growth factor reviews(IF=11.8). 2021. PMID:33551332. DOI: 10.1016/j.cytogfr.2021.01.006.
  • [26] Marios Kritsilis;Sophia V Rizou;Paraskevi N Koutsoudaki;Konstantinos Evangelou;Vassilis G Gorgoulis;Dimitrios Papadopoulos. Ageing, Cellular Senescence and Neurodegenerative Disease.. International journal of molecular sciences(IF=4.9). 2018. PMID:30261683. DOI: 10.3390/ijms19102937.
  • [27] Eva Prašnikar;Jure Borišek;Andrej Perdih. Senescent cells as promising targets to tackle age-related diseases.. Ageing research reviews(IF=12.4). 2021. PMID:33385543. DOI: 10.1016/j.arr.2020.101251.
  • [28] Nadja Anneliese Ruth Ring;Karla Valdivieso;Johannes Grillari;Heinz Redl;Mikolaj Ogrodnik. The role of senescence in cellular plasticity: Lessons from regeneration and development and implications for age-related diseases.. Developmental cell(IF=8.7). 2022. PMID:35472291. DOI: 10.1016/j.devcel.2022.04.005.
  • [29] Manas Ranjan Sahu;Linchi Rani;Rhea Subba;Amal Chandra Mondal. Cellular senescence in the aging brain: A promising target for neurodegenerative diseases.. Mechanisms of ageing and development(IF=5.1). 2022. PMID:35430158. DOI: 10.1016/j.mad.2022.111675.
  • [30] Abel Soto-Gamez;Marco Demaria. Therapeutic interventions for aging: the case of cellular senescence.. Drug discovery today(IF=7.5). 2017. PMID:28111332. DOI: 10.1016/j.drudis.2017.01.004.
  • [31] Henriette Thau;Bastian P Gerjol;Katharina Hahn;Rosalie Wolff von Gudenberg;Leonard Knoedler;Kenneth Stallcup;Maximilian Y Emmert;Timo Buhl;Saranya P Wyles;Tamar Tchkonia;Stefan G Tullius;Jasper Iske. Senescence as a molecular target in skin aging and disease.. Ageing research reviews(IF=12.4). 2025. PMID:39929368. DOI: 10.1016/j.arr.2025.102686.
  • [32] Esther Ugo Alum;Sylvester Chibueze Izah;Daniel Ejim Uti;Okechukwu Paul-Chima Ugwu;Peter A Betiang;Mariam Basajja;Regina Idu Ejemot-Nwadiaro. Targeting Cellular Senescence for Healthy Aging: Advances in Senolytics and Senomorphics.. Drug design, development and therapy(IF=5.1). 2025. PMID:40994903. DOI: 10.2147/DDDT.S543211.
  • [33] Sundeep Khosla;Joshua N Farr;David G Monroe. Cellular senescence and the skeleton: pathophysiology and therapeutic implications.. The Journal of clinical investigation(IF=13.6). 2022. PMID:35104801. DOI: .
  • [34] Laura Sánchez-Díaz;Asunción Espinosa-Sánchez;José-Ramón Blanco;Amancio Carnero. Senotherapeutics in Cancer and HIV.. Cells(IF=5.2). 2022. PMID:35406785. DOI: 10.3390/cells11071222.
  • [35] Tianlu Esther Fu;Zhongjun Zhou. Senescent cells as a target for anti-aging interventions: From senolytics to immune therapies.. Journal of translational internal medicine(IF=7.4). 2025. PMID:40115034. DOI: 10.1515/jtim-2025-0005.
  • [36] Wen Li;Lin Qin;Rennan Feng;Guangrong Hu;Hui Sun;Yonghan He;Rongping Zhang. Emerging senolytic agents derived from natural products.. Mechanisms of ageing and development(IF=5.1). 2019. PMID:31077707. DOI: 10.1016/j.mad.2019.05.001.
  • [37] Lokesh Chandrakar;Ramesh Ambatwar;Gopal L Khatik. Cellular Senescence and Senolytic Agents: Recent Updates on Their Role and Applications.. Current topics in medicinal chemistry(IF=3.3). 2024. PMID:38037999. DOI: 10.2174/0115680266273698231107110956.
  • [38] Domhnall McHugh;Imanol Durán;Jesús Gil. Senescence as a therapeutic target in cancer and age-related diseases.. Nature reviews. Drug discovery(IF=101.8). 2025. PMID:39548312. DOI: 10.1038/s41573-024-01074-4.
  • [39] Sundeep Khosla;Joshua N Farr;Tamara Tchkonia;James L Kirkland. The role of cellular senescence in ageing and endocrine disease.. Nature reviews. Endocrinology(IF=40.0). 2020. PMID:32161396. DOI: 10.1038/s41574-020-0335-y.
  • [40] Baukje Brattinga;Barbara L van Leeuwen. Senescent Cells: A Potential Target for New Cancer Therapies in Older Oncologic Patients.. Cancers(IF=4.4). 2021. PMID:33451087. DOI: 10.3390/cancers13020278.

MaltSci Intelligent Research Services ​

Search for more papers on MaltSci.com ​

Cellular Senescence · Aging · Healthspan

© 2025 MaltSci